About Miebo
Strength:
Topical Ophthalmic : The ophthalmic solution consists of 100% perfluorohexyloctane.
Recommended Dosage:
Miebo is an ophthalmic solution designed to provide relief and support for various eye conditions. When using Miebo, it’s important to follow the recommended dosing instructions for optimal results and to ensure the safety of your eyes.
Important
Before instilling the Miebo eye drop, it’s crucial to wash your hands thoroughly with soap and water to prevent any potential contamination. Gently shake the Miebo bottle to ensure that the solution is well-mixed. Then, using a clean and dry tissue or cloth, gently wipe any excess moisture from your eyes.
To drop the Miebo eye drop, tilt your head backward, look upward, and use one hand to pull down your lower eyelid gently, creating a small pocket. Hold the Miebo bottle with your other hand and carefully instill one drop into the pocket formed by the lower eyelid. Be cautious not to touch your eye with the dropper tip to avoid any contamination.
Warnings & Precautions
Common Miebo Side Effects:
Use in Specific Population
Storage and Handling
Sansfro follows a simple four-step protocol for medication procurement to ensure that patients can access the prescription drugs they need:
The Sansfro team will start In order to import medication, patients need to provide the following paperwork:
As soon as these documents are received, the Sansfro team will begin the import licence application process. This licence is a crucial prerequisite for getting the required medication after gaining government approval.
No news found.
Sansfro is committed to bridging the healthcare gap. Our purpose is to bring hope and healing to patients suffering from rare diseases by linking them with life-saving treatments through our Named Patient Program. Join us in our quest for a better and healthier world.
Know More...Is there any specific patient counseling information for Miebo?
Patients should be advised to remove contact lenses before using Miebo and wait for at least 30 minutes after administration before reinserting them. The administration instructions should be followed carefully for proper usage.
Is Miebo carcinogenic or mutagenic?
Long-term studies in animals have not been conducted to evaluate the carcinogenic potential of perfluorohexyloctane. Perfluorohexyloctane was not found to be mutagenic or clastogenic in various genotoxicity tests.
What is the mechanism of action for Miebo in treating dry eye disease (DED)?
While the exact mechanism of action for Miebo in treating DED is not known, it is believed that perfluorohexyloctane forms a monolayer at the air-liquid interface of the tear film, which can be expected to reduce evaporation.
Is perfluorohexyloctane safe for use in children?
The safety and effectiveness of perfluorohexyloctane eye drop in pediatric patients below the age of 18 years have not been established.
Can I use perfluorohexyloctane while breastfeeding?
The presence of perfluorohexyloctane in human milk and its effects on the breastfed infant are not known. It’s essential to weigh the potential benefits of breastfeeding against the clinical need for Miebo, taking into account the lack of clinical data during lactation.
What is the Miebo cost in India?
The price of Miebo cost in India is determined by individual product requirements. For further details, please contact our Patient Support Team at (+91) 93157 05373 or via email at help@sansfro.com.
How to Buy Miebo online?
As Miebo is exclusively available in the US and EU markets, individuals residing outside these regions must initiate the import process. Patients or their family members should contact an authorized pharmaceutical company to inquire about the availability and pricing of the medication.
Medical counselor
India, Andorra, Argentina, Australia, Austria, Azerbaijan, Bahrain, Brazil, Bulgaria, Cambodia, Canada, Chile, Colombia, Costa Rica, Croatia, Cyprus, Denmark, Dominican Republic, Estonia, Finland, France, Georgia, Germany, Ghana, Greece, Guatemala, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kenya, Kuwait, Latvia, Lebanon, Libya, Lithuania, Malawi, Mexico, Montenegro, Nepal, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Paraguay, Peru, Poland, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovenia, Spain, Sri Lanka, Sweden, Switzerland, United Arab Emirates, United Kingdom, United States, Venezuela, Zimbabwe, Afghanistan, Albania, Algeria, American Samoa, Angola, Anguilla, Antarctica, etc.